E. A. Papsheva

E. A. Papsheva

Auto-generated profile, based on publicly available information

E. A. Papsheva

Rostov State Medical University (Research Institute of Obstetrics and Pediatrics)

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2020 in Medical Herald of the South of Russia
Verified
Journal Article
Open access
PDF file
SBS. B. Berezhansky
S. B. Berezhansky
AAA. A. Afonin
A. A. Afonin
EPE. A. Papsheva
E. A. Papsheva
NVN. N. Vostrykh
N. N. Vostrykh
GGG. A. Galkina
G. A. Galkina
ELE. A. Lukyanova
E. A. Lukyanova
A clinical case of congenital hyperinsulinism, diffuse form, pharmacoresistant course (heterozygous mutation of p. 1361 1363 dup CGG in the GCK gene) in an early child is presented as an example of an orphan severe disease with an extremely unfavorable course and a probability of deterioration of the long-term prognosis. The goal was to highlight the clinical manifestations, course options, and complexity of treatment of this pathology to a wide range of doctors of different specialties in the field of Pediatrics in terms of improving the quality and timeliness of diagnosis, reducing the number of complications with the formation of irreparable consequences. Attention is drawn to the most severe course of hypoglycemic conditions in the early neonatal period, the dependence of the formation of a pronounced neurological deficit on the degree and duration of hypoglycemia, which emphasizes the importance of their timely correction to preserve the quality of life of this contingent of children.

20 December 2020 in Medical Herald of the South of Russia
Verified
Journal Article
Open access
PDF file
ALA. A. Lebedenko
A. A. Lebedenko
SBS. B. Berezhanskay
S. B. Berezhanskay
ATA. S. Todorova
A. S. Todorova
NVN. N. Vostrykh
N. N. Vostrykh
EKE. Y. Kaushanskay
E. Y. Kaushanskay
ЕКЕ. Я. Каушанская
Е. Я. Каушанская
Glutaric aciduria type I (deficiency of glutaryl-COA dehydrogenase, glutaric acidemia type I) is a rare autosomal recessive disease caused by mutations in the gene encoding the enzyme glutaryl – COA - dehydrogenase (GCDH). Cerebral organic aciduria, caused by a deficiency of glutaryl-COA - dehydrogenase, is generally considered a neurological disorder.The phenotypic spectrum of untreated GA-1 varies from a more common and pronounced form (a disease with infancy) to a low-symptom and less common form. In people with the same genotype, the clinical manifestations and depth of CNS damage can vary widely depending on the age of manifestation of acute encephalopathic crises. It is assumed that with early detection and treatment of “asymptomatic” newborns (in the context of screening for this disease), most people who would have developed manifestations of GA-1 with childhood or late onset will remain asymptomatic.